epirubicin has been researched along with Melanoma in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (52.94) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Góralczyk, A; Wróblewska-Łuczka, P; Łuszczki, JJ | 2 |
| Dorval, T; Lantz, O; Louis, D; Milder, M; Péguillet, I; Piperno-Neumann, S; Scholl, SM; Vincent-Salomon, A | 1 |
| Chen, J; Chen, X; Li, N; Liu, Y; Sun, Q; Wang, B | 1 |
| Baldi, A; Citro, G; Fanciulli, M; Spugnini, EP | 1 |
| Ahmed, AS; Dellinger, RW; Duong, PH; Matundan, HH; Meyskens, FL | 1 |
| Di Lauro, L; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
| Ganzina, F | 1 |
| Barduagni, A; Di Lauro, L; Ganzina, F; Lopez, M; Papaldo, P; Perno, CF | 2 |
| Berman, E; Casper, ES; Howard, J; Wittes, RE | 1 |
| Gandara, DR; Gribble, M; Kohler, M; Meyers, FJ; Mitchell, E; Porzig, KJ; Torti, FM; Volberding, P | 1 |
| Ferrazzi, E; Fiorentino, MV; Ganzina, F; Maraglino, G; Nicoletto, O; Pagnin, P; Vinante, O | 1 |
| Borden, EC; Green, M; Haller, DG; Marsh, JC; Rosenthal, MA; Wiernik, P | 1 |
| Amicucci, G; Deraco, M; Fiorentini, G; Guadagni, S; Miotto, D; Palumbo, G; Pilati, PL; Rossi, CR; Russo, F; Santinami, M; Valenti, M | 1 |
| Cersosimo, RJ; Hong, WK | 1 |
| Geran, R; Goldin, A; Venditti, JM | 1 |
4 review(s) available for epirubicin and Melanoma
| Article | Year |
|---|---|
Preclinical models in electrochemotherapy: the role of veterinary patients.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cat Diseases; Cats; Cisplatin; Dog Diseases; Dogs; Drug Evaluation, Preclinical; Electrochemotherapy; Epirubicin; Head and Neck Neoplasms; Melanoma; Mitoxantrone; Neoplasms; Quinazolines; Sarcoma; Thiophenes | 2012 |
4'-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Chemical Phenomena; Chemistry; Colonic Neoplasms; Dogs; Doxorubicin; Epirubicin; Female; Heart; Humans; Kidney Neoplasms; Male; Melanoma; Mutagenicity Tests; Neoplasms, Experimental; Rabbits | 1983 |
Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
Topics: Bone Marrow; Breast Neoplasms; Carcinoma, Renal Cell; Carcinoma, Small Cell; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Head and Neck Neoplasms; Heart; Humans; Kidney Neoplasms; Kinetics; Leukemia; Liver Neoplasms; Lung Neoplasms; Lymphoma; Male; Melanoma; Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Soft Tissue Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms | 1986 |
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Topics: Animals; Antibiotics, Antineoplastic; Colonic Neoplasms; Doxorubicin; Drug Administration Schedule; Drug Evaluation, Preclinical; Epirubicin; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Neoplasm Transplantation; Neoplasms, Experimental | 1985 |
3 trial(s) available for epirubicin and Melanoma
| Article | Year |
|---|---|
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Epirubicin; Female; Heart; Humans; Male; Melanoma; Middle Aged | 1984 |
Epirubicin has modest single-agent activity in head and neck cancer but limited activity in metastatic melanoma and colorectal cancer: phase II studies by the Eastern Cooperative Oncology Group.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Colorectal Neoplasms; Epirubicin; Female; Head and Neck Neoplasms; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1998 |
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Disease Progression; Disease-Free Survival; Epirubicin; Female; Hemodynamics; Humans; Hypoxia; Leg; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Pelvis; Skin Neoplasms; Treatment Outcome | 2002 |
10 other study(ies) available for epirubicin and Melanoma
| Article | Year |
|---|---|
Synergy, Additivity and Antagonism between Esculetin and Six Commonly Used Chemotherapeutics in Various Malignant Melanoma Cell Lines-An Isobolographic Analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Cisplatin; Cytostatic Agents; Docetaxel; Epirubicin; Humans; Melanoma; Mitoxantrone; Paclitaxel; Vemurafenib | 2023 |
Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.
Topics: Cisplatin; Coumarins; Cytostatic Agents; Docetaxel; Epirubicin; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mitoxantrone; Vemurafenib | 2023 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Lymphocytes; Cell Differentiation; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Leukapheresis; Melanoma; Neoadjuvant Therapy; T-Lymphocyte Subsets; Taxoids; Uveal Neoplasms | 2014 |
CYR61 suppresses growth of human malignant melanoma.
Topics: Animals; Antibodies, Monoclonal; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cysteine-Rich Protein 61; Epirubicin; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Melanoma; Melanoma, Experimental; Mice; Neoplasm Metastasis; Skin Neoplasms | 2016 |
Anti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Gene Expression Regulation; Gene Knockdown Techniques; Glucuronosyltransferase; Humans; Indoles; Melanocytes; Melanoma; Sulfonamides; Temozolomide; Vemurafenib | 2012 |
[Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Lymphoma; Male; Melanoma; Middle Aged; Stereoisomerism | 1984 |
Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Time Factors | 1984 |
Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Stereoisomerism | 1984 |
Phase II study of epirubicin in advanced malignant melanoma.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Blood; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Melanoma; Middle Aged | 1984 |
Phase II study of 4'epi-doxorubicin.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Female; Heart; Humans; Male; Melanoma; Middle Aged; Neoplasms; Sarcoma | 1982 |